Melanoma- Staging, Immunotherapies, Genetic Testing

Mar 2, 2017 3:00pm ‐ Mar 2, 2017 4:00pm


Description

Do you really understand the risk factors for developing melanoma? Do you really understand the specifics of patient's melanoma diagnosis? Are you confused by the pathology report, any genetic testing, and how to really stage a melanoma? If so, then this session is for you! By attending this session, you will learn what the risk factors REALLY are for developing melanoma and better understand the "genetics". You will be able to stage your patient's melanoma based on the current staging, and then get a jump start on learning about the revisions being incorporated into next edition (AJCC 8th edition), effective 2018. The treatment landscape of advanced melanoma will be described comparing and contrasting the various modalities. Case studies will be used throughout the session. If you want to enhance your melanoma knowledge, this session is for you!

Learning Objectives:

  • Review the epidemiology of & risk factors for melanoma
  • List the essential components of a pathology report and evaluate in the current AJCC staging system
  • Differentiate types of mutations in melanoma (germline vs somatic)
  • Compare & contrast immunotherapy versus targeted therapy
  • Examine current & future treatment strategies for advanced melanoma
  • Discuss combinations therapies
  • Describe investigational use of new agents

Speaker(s):

  • Krista Rubin, MS, FNP-BC, Nurse Practitioner, Center for Melanoma, Massachusetts General Hospital

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content